Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $1.91 $2.42 Friday, 10th May 2024 CANF stock ended at $2.09. This is 2.42% less than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 3.29% from a day low at $2.05 to a day high of $2.12.
90 days $1.91 $2.71
52 weeks $1.81 $3.33

Historical Can-Fite BioPharma Ltd prices

Date Open High Low Close Volume
Jan 03, 2017 $2.40 $2.43 $2.33 $2.38 34 482
Dec 30, 2016 $2.41 $2.49 $2.37 $2.38 44 220
Dec 29, 2016 $2.40 $2.49 $2.34 $2.46 32 987
Dec 28, 2016 $2.45 $2.47 $2.40 $2.43 21 536
Dec 27, 2016 $2.33 $2.54 $2.31 $2.42 97 644
Dec 23, 2016 $2.43 $2.44 $2.39 $2.42 40 218
Dec 22, 2016 $2.33 $2.51 $2.33 $2.43 69 104
Dec 21, 2016 $2.35 $2.37 $2.30 $2.37 69 459
Dec 20, 2016 $2.30 $2.39 $2.28 $2.38 63 336
Dec 19, 2016 $2.31 $2.41 $2.28 $2.33 50 153
Dec 16, 2016 $2.25 $2.45 $2.16 $2.33 466 222
Dec 15, 2016 $2.13 $2.19 $2.12 $2.14 33 571
Dec 14, 2016 $2.02 $2.16 $2.02 $2.16 35 100
Dec 13, 2016 $2.03 $2.11 $1.96 $2.00 96 200
Dec 12, 2016 $2.15 $2.23 $2.06 $2.11 33 800
Dec 09, 2016 $2.09 $2.20 $2.09 $2.20 15 300
Dec 08, 2016 $2.20 $2.20 $2.12 $2.12 39 100
Dec 07, 2016 $2.23 $2.23 $2.12 $2.16 52 700
Dec 06, 2016 $2.20 $2.25 $2.17 $2.23 28 700
Dec 05, 2016 $2.17 $2.30 $2.16 $2.18 65 600
Dec 02, 2016 $2.15 $2.20 $2.10 $2.20 24 000
Dec 01, 2016 $2.18 $2.22 $2.15 $2.15 63 100
Nov 30, 2016 $2.27 $2.29 $2.20 $2.20 28 900
Nov 29, 2016 $2.30 $2.30 $2.25 $2.26 4 300
Nov 28, 2016 $2.32 $2.32 $2.21 $2.30 29 500
Click to get the best stock tips daily for free!

About Can-Fite BioPharma Ltd

Can-Fite BioPharma Ltd Can-Fite BioPharma Ltd., a clinical-stage biopharmaceutical company, develops small molecule therapeutic products for the treatment of cancer, liver inflammatory diseases, and erectile dysfunction. The company's lead drug candidate Piclidenoson, which has been completed Phase III clinical trial for the treatment of psoriasis; and Phase II clinical trial for the treatment of COVID-19. It also develops Namodenoson that is in Phase III clinical tria... CANF Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT